Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Xolare RCR Energy Tbk. (SOLA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Xolare RCR Energy Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Xolare RCR Energy Tbk. diperdagangkan di Rp91 (kapitalisasi pasar 305,73 M, volume 24 jam 5,23 jt). Perbedaan utamanya: Xolare RCR Energy Tbk. jauh lebih besar — sekitar 2,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SOLA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 305,73 M |
Volume | — | 5,23 jt |
Lot | — | 52,32 rb |
Perputaran | — | 472,84 jt |
Harga Rata-rata | — | 90,37 |
Nilai Transaksi | — | 472,84 jt |
Harga Ekuilibrium Indikatif | — | 91 |
Volume Ekuilibrium Indikatif | — | 942 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Xolare RCR Energy Tbk.
PT Xolare RCR Energy (Formerly: PT RCR Energy Indonesia) (the "Company") was established based on Notarial Deed No. 213 dated December 18, 2014 drawn up before Notary Humberg Lie, S.H., S.E., M.Kn., in Jakarta. The ultimate beneficial owner of the Company is PT Energi Hijau Investama. The Company started its commercial activities in 2015.
Selengkapnya di halaman SOLA →
